Hrt Financial LP Relay Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $15.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$6.01 - $11.48 $246,367 - $470,599
-40,993 Reduced 40.18%
61,039 $672,000
Q3 2023

Nov 13, 2023
BUY
$8.24 - $12.97 $539,991 - $849,963
65,533 Added 179.55%
102,032 $858,000
Q2 2023

Aug 11, 2023
BUY
$9.99 - $18.27 $364,625 - $666,836
36,499 New
36,499 $458,000

Others Institutions Holding RLAY

# of Institutions
187
Shares Held
127M
Call Options Held
4.2K
Put Options Held
1.7K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $834M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email